RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Shedir Pharma Srl Unipersonale Stock

Shedir Pharma Srl Unipersonale ROE 2024

Shedir Pharma Srl Unipersonale ROE

0.16

Ticker

SHE.MI

ISIN

IT0005379620

In 2024, Shedir Pharma Srl Unipersonale's return on equity (ROE) was 0.16, a -12.35% increase from the 0.18 ROE in the previous year.

Shedir Pharma Srl Unipersonale Aktienanalyse

What does Shedir Pharma Srl Unipersonale do?

Shedir Pharma Srl Unipersonale ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Shedir Pharma Srl Unipersonale's Return on Equity (ROE)

Shedir Pharma Srl Unipersonale's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Shedir Pharma Srl Unipersonale's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Shedir Pharma Srl Unipersonale's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Shedir Pharma Srl Unipersonale’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Shedir Pharma Srl Unipersonale stock

What is the ROE (Return on Equity) of Shedir Pharma Srl Unipersonale this year?

The ROE of Shedir Pharma Srl Unipersonale this year is 0.16 undefined.

How has the Return on Equity (ROE) of Shedir Pharma Srl Unipersonale developed compared to the previous year?

The ROE of Shedir Pharma Srl Unipersonale has increased by -12.35% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Shedir Pharma Srl Unipersonale?

A high ROE indicates that Shedir Pharma Srl Unipersonale generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Shedir Pharma Srl Unipersonale?

A low ROE can indicate that Shedir Pharma Srl Unipersonale is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Shedir Pharma Srl Unipersonale affect the company?

A change in ROE (Return on Equity) of Shedir Pharma Srl Unipersonale can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Shedir Pharma Srl Unipersonale?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Shedir Pharma Srl Unipersonale?

Some factors that can influence Shedir Pharma Srl Unipersonale's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Shedir Pharma Srl Unipersonale pay?

Over the past 12 months, Shedir Pharma Srl Unipersonale paid a dividend of 0.34 EUR . This corresponds to a dividend yield of about 9.08 %. For the coming 12 months, Shedir Pharma Srl Unipersonale is expected to pay a dividend of 0.38 EUR.

What is the dividend yield of Shedir Pharma Srl Unipersonale?

The current dividend yield of Shedir Pharma Srl Unipersonale is 9.08 %.

When does Shedir Pharma Srl Unipersonale pay dividends?

Shedir Pharma Srl Unipersonale pays a quarterly dividend. This is distributed in the months of June, June, June, June.

How secure is the dividend of Shedir Pharma Srl Unipersonale?

Shedir Pharma Srl Unipersonale paid dividends every year for the past 6 years.

What is the dividend of Shedir Pharma Srl Unipersonale?

For the upcoming 12 months, dividends amounting to 0.38 EUR are expected. This corresponds to a dividend yield of 10.1 %.

In which sector is Shedir Pharma Srl Unipersonale located?

Shedir Pharma Srl Unipersonale is assigned to the 'Health' sector.

Wann musste ich die Aktien von Shedir Pharma Srl Unipersonale kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Shedir Pharma Srl Unipersonale from 5/10/2023 amounting to 0.175 EUR, you needed to have the stock in your portfolio before the ex-date on 5/8/2023.

When did Shedir Pharma Srl Unipersonale pay the last dividend?

The last dividend was paid out on 5/10/2023.

What was the dividend of Shedir Pharma Srl Unipersonale in the year 2023?

In the year 2023, Shedir Pharma Srl Unipersonale distributed 0.13 EUR as dividends.

In which currency does Shedir Pharma Srl Unipersonale pay out the dividend?

The dividends of Shedir Pharma Srl Unipersonale are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Shedir Pharma Srl Unipersonale

Our stock analysis for Shedir Pharma Srl Unipersonale Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Shedir Pharma Srl Unipersonale Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.